Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

5.05
Delayed Data
As of 12:14pm ET
 -0.0465 / -0.91%
Today’s Change
4.00
Today|||52-Week Range
6.90
-7.28%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close5.10
Today’s open5.10
Day’s range4.95 - 5.10
Volume40,543
Average volume (3 months)118,165
Market cap$141.7M
Dividend yield--
Data as of 12:14pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-42.42%
Earnings growth (this year)+12.77%
Earnings growth (next 5 years)--
Revenue growth (last year)+98.84%
P/E ratioNM
Price/Sales14.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...+0.20+2.67%
CDXCChromadex Corp+0.04+1.35%
NVLNNovelion Therapeutic...-0.06-0.59%
NATRNatures Sunshine Pro...-0.15-1.49%
Data as of 12:15pm ET, 04/28/2017

Financials

Next reporting dateMay 17, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$9.5M
Annual profit (last year)-$11.9M
Net profit margin-125.31%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts